Cited 0 times in
The effect of intracoronary nicorandil on coronary myocardial bridging
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 민필기 | - |
dc.contributor.author | 이상학 | - |
dc.contributor.author | 장양수 | - |
dc.date.accessioned | 2015-04-24T16:48:45Z | - |
dc.date.available | 2015-04-24T16:48:45Z | - |
dc.date.issued | 2009 | - |
dc.identifier.issn | 1074-2484 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/104218 | - |
dc.description.abstract | Medical treatments of coronary myocardial bridging (CMB) generally include beta-blockers and calcium channel blockers. Nitrates are avoided because symptoms may worsen. Nicorandil is a hybrid of a nitrate and a potassium channel opener. However, the effect of nicorandil on CMB is unknown. We analyzed nicorandil reactivity at the site with CMB in 51 patients. Maximal and minimal diameters of CMB were measured by quantitative angiography at baseline and at 60 seconds after intracoronary administration of 200 mg nicorandil. The maximal diameter during diastole increased from 2.15 + 0.42 mm to 2.34 + 0.44 mm after administration of nicorandil (P < .001), and the minimal diameter during systole increased from 1.24 + 0.63 mm to 1.67 + 0.64 mm (P < .001). Thus, nicorandil reduced the percentage vessel narrowing from 44.0 + 26.1% to 30.3 + 21.2% (P < .001). In 22 patients, we also evaluated the effect of nitroglycerin. The maximal diameter during diastole increased from 2.25 + 0.47 mm to 2.51 + 0.44 mm after administration of nitroglycerin (P < .019), and the minimal diameter during systole decreased from 1.28 + 0.64 mm to 1.14 + 0.60 mm (P = .276). Thus, nitroglycerin augmented the percentage vessel narrowing from 44.9% + 25.0% to 56.0% + 23.5% (P = .023). These results indicate that intracoronary administration of nicorandil could dilate coronary arteries during diastole as well as systole in patients with CMB during coronary angiography. | - |
dc.description.statementOfResponsibility | open | - |
dc.format.extent | 180~184 | - |
dc.relation.isPartOf | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.subject.MESH | Coronary Angiography | - |
dc.subject.MESH | Coronary Vessels/drug effects* | - |
dc.subject.MESH | Coronary Vessels/physiopathology | - |
dc.subject.MESH | Female | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Male | - |
dc.subject.MESH | Middle Aged | - |
dc.subject.MESH | Myocardial Bridging/diagnostic imaging | - |
dc.subject.MESH | Myocardial Bridging/drug therapy* | - |
dc.subject.MESH | Myocardial Bridging/physiopathology | - |
dc.subject.MESH | Nicorandil/administration & dosage* | - |
dc.subject.MESH | Prospective Studies | - |
dc.subject.MESH | Treatment Outcome | - |
dc.subject.MESH | Vasodilation/drug effects* | - |
dc.subject.MESH | Vasodilator Agents/administration & dosage* | - |
dc.title | The effect of intracoronary nicorandil on coronary myocardial bridging | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학) | - |
dc.contributor.googleauthor | Jae-Hun Jung | - |
dc.contributor.googleauthor | Pil-Ki Min | - |
dc.contributor.googleauthor | Chong Won Sung | - |
dc.contributor.googleauthor | Sang-Hak Lee | - |
dc.contributor.googleauthor | Seonghoon Choi | - |
dc.contributor.googleauthor | Jung Rae Cho | - |
dc.contributor.googleauthor | Namho Lee | - |
dc.contributor.googleauthor | Kyoung-Ha Park | - |
dc.contributor.googleauthor | Min-Kyu Kim | - |
dc.contributor.googleauthor | Woo Jung Park | - |
dc.contributor.googleauthor | Yangsoo Jang | - |
dc.identifier.doi | 10.1177/1074248409338930 | - |
dc.admin.author | false | - |
dc.admin.mapping | false | - |
dc.contributor.localId | A01412 | - |
dc.contributor.localId | A03448 | - |
dc.contributor.localId | A02833 | - |
dc.relation.journalcode | J01297 | - |
dc.identifier.eissn | 1940-4034 | - |
dc.identifier.pmid | 19605572 | - |
dc.identifier.url | http://cpt.sagepub.com/content/14/3/180 | - |
dc.subject.keyword | angina pectoris | - |
dc.subject.keyword | myocardial bridging | - |
dc.subject.keyword | nicorandil | - |
dc.contributor.alternativeName | Min, Pil Ki | - |
dc.contributor.alternativeName | Lee, Sang Hak | - |
dc.contributor.alternativeName | Jang, Yang Soo | - |
dc.contributor.affiliatedAuthor | Min, Pil Ki | - |
dc.contributor.affiliatedAuthor | Jang, Yang Soo | - |
dc.contributor.affiliatedAuthor | Lee, Snag Hak | - |
dc.citation.volume | 14 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 180 | - |
dc.citation.endPage | 184 | - |
dc.identifier.bibliographicCitation | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, Vol.14(3) : 180-184, 2009 | - |
dc.identifier.rimsid | 56120 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.